| Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... The Lancet 393 (10185), 2051-2058, 2019 | 1801 | 2019 |
| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ... The lancet oncology 16 (6), 630-637, 2015 | 1679 | 2015 |
| Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional … DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ... Journal of Clinical Oncology 37 (18), 1558-1565, 2019 | 1208 | 2019 |
| Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic … DR Gomez, GR Blumenschein, JJ Lee, M Hernandez, R Ye, DR Camidge, ... The lancet oncology 17 (12), 1672-1682, 2016 | 1104 | 2016 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... Journal of Clinical Oncology 38 (25), 2830-2838, 2020 | 1061 | 2020 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 335 | 2001 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ... BMC cancer 19, 1-15, 2019 | 229 | 2019 |
| Management of metastatic clear cell renal cell carcinoma: ASCO guideline WK Rathmell, RB Rumble, PJ Van Veldhuizen, H Al-Ahmadie, ... Journal of Clinical Oncology 40 (25), 2957-2995, 2022 | 202 | 2022 |
| Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: physician performance versus radiomic assessment SA Mattonen, DA Palma, C Johnson, AV Louie, M Landis, G Rodrigues, ... International Journal of Radiation Oncology* Biology* Physics 94 (5), 1121-1128, 2016 | 169 | 2016 |
| Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) S Siva, AV Louie, A Warner, A Muacevic, S Gandhidasan, L Ponsky, ... Cancer 124 (5), 934-942, 2018 | 168 | 2018 |
| Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes S Harrow, DA Palma, R Olson, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... International Journal of Radiation Oncology* Biology* Physics 114 (4), 611-616, 2022 | 158 | 2022 |
| Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review H Chen, S Senan, EJ Nossent, RG Boldt, A Warner, DA Palma, AV Louie International Journal of Radiation Oncology* Biology* Physics 98 (3), 622-631, 2017 | 155 | 2017 |
| Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era AV Louie, G Rodrigues, J Olsthoorn, D Palma, E Yu, B Yaremko, B Ahmad, ... Radiotherapy and Oncology 95 (2), 166-171, 2010 | 152 | 2010 |
| Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach S Siva, G Kothari, A Muacevic, AV Louie, BJ Slotman, BS Teh, SS Lo Nature Reviews Urology 14 (9), 549-563, 2017 | 142 | 2017 |
| Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non–small-cell lung cancer WA Stokes, MR Bronsert, RA Meguid, MG Blum, BL Jones, M Koshy, ... Journal of clinical oncology 36 (7), 642-651, 2018 | 140 | 2018 |
| Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies NG Zaorsky, EJ Lehrer, G Kothari, AV Louie, S Siva European urology oncology 2 (5), 515-523, 2019 | 137 | 2019 |
| Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons AV Louie, DA Palma, M Dahele, GB Rodrigues, S Senan Radiotherapy and Oncology 114 (2), 138-147, 2015 | 134 | 2015 |
| The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis RJM Correa, AV Louie, NG Zaorsky, EJ Lehrer, R Ellis, L Ponsky, I Kaplan, ... European urology focus 5 (6), 958-969, 2019 | 133 | 2019 |
| Epidemiology of bone metastases C Ryan, KC Stoltzfus, S Horn, H Chen, AV Louie, EJ Lehrer, DM Trifiletti, ... Bone 158, 115783, 2022 | 129 | 2022 |
| Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial DA Palma, RA Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, ... International Journal of Radiation Oncology, Biology, Physics 102 (3), S3-S4, 2018 | 123 | 2018 |
David PalmaWestern UniversityEmail được xác minh tại lhsc.on.ca